Predictors of adherence to atypical antipsychotics (risperidone or olanzapine) in older patients with schizophrenia: an open study of 3½ years duration-Reference-Cited by-同舟云学术

Predictors of adherence to atypical antipsychotics (risperidone or olanzapine) in older patients with schizophrenia: an open study of 3½ years duration

Published:2010-04 Issue:4 Volume:25 Page:411-418
ISSN:0885-6230
Container-title:International Journal of Geriatric Psychiatry
language:en
Short-container-title:Int. J. Geriat. Psychiatry

Author:

Ritchie C. W.,Harrigan S.,Mastwyk M.,Macfarlane S.,Cheesman N.,Ames D.

Publisher

Wiley

Subject

Psychiatry and Mental health,Geriatrics and Gerontology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/gps.2354/fullpdf

Reference21 articles.

1. Arunpongpaisal S, Ahmed I, Aqeel N, Paholpak S. 2003. Antipsychotic drug treatment for elderly people with late-onset schizophrenia. Cochrane Database Systematic Reviews (2) CD004162.

2. Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia;Ascher-Svanum;BMC Psychiatr,2006

3. Ambulatory use of olanzapine and risperidone: a population-based study on persistence and the use of concomitant therapy in the treatment of schizophrenia;Cooper;Can J Psychiatr,2005

4. Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia;Cooper;J Clin Psychiatr,2007

5. Determinants of medication compliance in schizophrenia: empirical and clinical findings;Fenton;Schizophr Bull,1997

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia;The Journal of Clinical Psychiatry;2022-06-01

2. Factors Influencing Adherence to Antipsychotic Medications in Women with Delusional Disorder: A Narrative Review;Current Pharmaceutical Design;2022-05

3. Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics and Suicide and All-Cause Mortality in Patients With Newly Diagnosed Schizophrenia;JAMA Network Open;2021-05-11

4. The effectiveness of long‐acting injectable antipsychotics versus oral antipsychotics in the maintenance treatment of outpatients with chronic schizophrenia;Human Psychopharmacology: Clinical and Experimental;2020-03-17

5. Long‐term effectiveness of oral second‐generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta‐analysis of direct head‐to‐head comparisons;World Psychiatry;2019-05-06